Lanthanide-catalyzed hydroamination of hindered alkenes in synthesis: Rapid access to 10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines

Journal of Organic Chemistry

Volumn 64, Issue 17, 1999, Pages 6515-6517

  Molander, Gary A ^a,b   Dowdy, Eric D ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5,10 IMINE; ALKENE; DIZOCILPINE; IMINE; LANTHANIDE; UNCLASSIFIED DRUG;

AMINATION; ANTICONVULSANT ACTIVITY; ARTICLE; CATALYSIS; CYCLIZATION; DRUG SYNTHESIS; HYDROGENATION; MOLECULAR INTERACTION; NEUROPROTECTION; REACTION ANALYSIS; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 0033588389     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo990626b     Document Type: Article

References (32)

1. (a) Molander, G. A. Chem. Rev. 1992, 92, 29.
2. (b) Molander, G. A.; Harris, C. R. Chem. Rev. 1996, 96, 307.
3. (c) Molander, G. A. Acc. Chem. Res. 1998, 31, 603.
4. Hegedus, L. S. Transition Metals in the Synthesis of Complex Organic Molecules; University Science Books: Mill Valley, CA, 1994.
5. Schumann, H.; Meese-Marktscheffel, J. A.; Esser, L. Chem. Rev. 1995, 95, 865.
6. (a) Marks T. J.; Ernst R. D. In Comprehensive Organometallic Chemistry; Wilkinson G., Stone, F. G. A., Abel E. W., Eds.; Pergamon Press: Oxford, 1982; Vol. 3, Chapter 21.
7. (b) Watson P. L.; Parshall G. W. Acc. Chem. Res. 1985, 18, 51.
8. (c) Edelmann F. T. In Comprehensive Organometallic Chemistry II; Abel E. W., Stone F. G. A., Wilkinson G., Eds.; Pergamon Press: Oxford, 1995; Vol. 4, Chapter 2.
9. (d) Edelmann F. T. Top. Curr. Chem. 1996, 179, 247.
10. (a) Molander, G. A. Chemtracts 1998, 11, 237.
11. (b) Molander, G. A.; Dowdy E. D. In Topics In Organometallic Chemistry; Kobayashi, S., Ed.; Springer-Verlag: New York, 1999; Vol. 2, pp 120-154.
12. Gagné, M. R.; Stern, C. L.; Marks, T. J. J. Am. Chem. Soc. 1992, 114, 275.
13. (a) Molander, G. A.; Dowdy, E. D.; Schumann, H. J. Org. Chem. 1998, 63, 3386.
14. (b) Molander, G. A.; Nichols, P. J. J. Org. Chem. 1998, 63, 2292.
15. (c) Molander, G. A.; Retsch, W. H. J. Org. Chem. 1998, 63, 5507.
16. (a) Li, Y.; Marks, T. J. J. Am. Chem. Soc. 1996, 118, 9295.
17. (b) Li, Y.; Marks T. J. J. Am. Chem. Soc. 1998, 120, 1757.
18. Molander, G. A.; Dowdy, E. D. J. Org. Chem. 1998, 63, 8983.
19. (a) Christy, M. E.; Anderson, P. S.; Britcher, S. F.; Colton, C. D.; Evans, B. E.; Remy, D. C.; Engelhardt, E. L. J. Org. Chem. 1979, 44, 3117.
20. (b) Yasuda, M.; Wakisaka, T.; Kojima, R.; Tanabe, K.; Shima, K. Bull. Chem. Soc. Jpn. 1995, 68, 3169.
21. (c) Evans, B. E.; Anderson, P. S.; Christy, M. E.; Colton, C. D.; Remy, D. C.; Rittle, K. E.; Engelhardt, E. L. J. Org. Chem. 1979, 44, 3127.
22. (a) Piwinski, J. J.; Wong, J. K; Green, M. J.; Ganguly, A. K.; Billah, M. M.; West, R. E., Jr.; Kreutner, W. J. Med. Chem. 1991, 34, 457.
23. (b) Jung, M. E.; Miller, S. J. J. Am. Chem. Soc. 1981, 103, 1984.
24. (c) Nomoto, T.; Takayama, H. J. Chem. Soc., Chem. Commun. 1982, 1113.
25. (d) Moore, A. Drugs Today (Barcelona) 1978, 14, 467.
26. Rajev, S.; Sharp, F. R. In Highly Selective Neurotoxins: Basic and Clinical Applications; Kostrzewa, R. M., Ed.; Humana Press: Totowa, NJ, 1998; pp 355-384.
27. Fitjer, L.; Quabech, U. Synth. Commun. 1985, 15, 855.
28. Dubey, S. K.; Kumar, S. J. Org. Chem. 1986, 51, 3407.
29. Meyers, A. I.; Higashiyama, K. J. Org. Chem. 1987, 52, 4592.
30. Simon, C.; Hosztafi, S.; Makleit, S. Tetrahedron Lett. 1993, 34, 6475.
31. Molander, G. A.; Dowdy, E. D.; Noll B. C. Organometallics 1998, 17, 3754.
32. Keitsch, M. Unpublished results.